Breaking Finance News

A statement released earlier today by Exane BNP Paribas about Victrex PLC (LON:VCT) bumps the target price to 1,450.00GBX

Yesterday Victrex PLC (LON:VCT) traded 0.07% lower at 1,501.50GBX. The company’s 50-day average is 1,519.51GBX and its two hundred day moving average is 1,517.21GBX. With the last stock price down 0.54% relative to the two hundred day average, compared to the S&P 500 which has fallen -0.01% over the same time. Trading volume was was down over the average, with 100,566 shares of VCT changing hands under the typical 271,380 shares..

Stating a possible downside of -0.03%, Exane BNP Paribas raised the price target of Victrex PLC (LON:VCT) to 1,450GBX

On 9/1/2016, Exane BNP Paribas released a statement for Victrex PLC(LON:VCT) held the target price at 1,530.00GBX that suggested an upside of 0.00%.

Recent Performance Chart:

Victrex PLC (LON:VCT)

A total of 15 brokerages have issued a ratings update on VCT. Four analysts rate the stock a strong buy, two analysts rate the company a buy, nine firms rate the stock a hold, one brokerage rate the stock to underperform, and finally 0 firmsrate the company as sell with a one year target price of 1,716.00GBX

With a market cap of 0.0 GBX, Victrex PLC has a one-year low of 1,275.58GBX and a 52 week high of 1,961.00GBX with a price-earnings ratio of 16.

General Company Details For Victrex PLC (LON:VCT)

Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of high performance polymers. The Company’s operating segments are Victrex Polymer Solutions and Invibio Biomaterial Solutions. The Victrex Polymer Solutions segment focuses on its automotive, aerospace, electronics and energy markets. The Invibio Biomaterial Solutions segment focuses on providing specialist solutions for medical device manufacturers. It offers its services to over 15, 000 aircrafts in approximately 40 countries across the world. The Company intends to focus on polyaryletherketones (PAEK) in automotive, aerospace, electronics and energy, downstream integration opportunities and extending into other markets. It also focuses on spine, trauma, dental and orthopedics, delivering solutions based on polyetheretherketone (PEEK) and other enabling polymers. The Company’s subsidiaries include Victrex Manufacturing Limited, and Invibio Limited and Victrex Trading Limited.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.